Abstract
IntroductionProcess evaluations accompanying complex interventions examine the implementation process of the underlying intervention, identify mechanisms of impact and assess contextual factors. This paper presents the protocol for a process evaluation conducted alongside the randomised controlled trial POWER@MS2. The trial comprises the evaluation of a web-based complex intervention on relapse management in 188 people with multiple sclerosis conducted in 20 centres. The web-based intervention programme focuses on relapse treatment decision making and includes a decision aid, a nurse-led webinar and an online chat. With the process evaluation presented here, we aim to assess participants’ responses to and interactions with the intervention to understand how and why the intervention produces change.Methods and analysisA mixed methods design is used to explore the acceptance of the intervention as well as its use and impact on participants. Participants are people with multiple sclerosis, neurologists, nurses and stakeholders. Quantitative semistandardised evaluation forms will be collected throughout the study. Qualitative semistructured telephone interviews will be conducted at the end of the study with selected participants, especially people with multiple sclerosis and neurologists. Quantitative data will be collected and analysed descriptively. Based on the results, the qualitative interviews will be conducted and analysed thematically, and the results will be merged in a joint display table.Ethics and disseminationThe process evaluation has received ethical approval from the Ethical Committee of the University of Lübeck (reference 19–024). Findings will be disseminated in peer-reviewed journals, at conferences, meetings and on relevant patient websites.Trial registration numberNCT04233970.
Funder
German Innovation Fund of the Federal Joint Committee
Reference34 articles.
1. World Health Organisation . Atlas multiple sclerosis resources in the world 2008. Geneva: WHO Press, 2008.
2. Holstiege J , Steffen A , Goffrier B , et al . Epidemiologie der Multiplen Sklerose-eine populationsbasierte deutschlandweite Studie. Zentralinstitut für die kassenärztliche Versorgung Deutschl, 2017. Available: http://www.versorgungsatlas.de/themen/alle-analysen-nach-datum-sortiert/?tab=6&uid=86 [Accessed 22 Apr 2020].
3. Epidemiologie der Multiplen Sklerose in Deutschland. Regionale Unterschiede und Versorgungsstruktur in Abrechnungsdaten der gesetzlichen Krankenversicherung;Petersen;Nervenarzt,2014
4. Update zu Diagnostik und therapie;Flachenecker;Neuroreha,2019
5. Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials;Lavery;Mult Scler Int,2014
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献